# Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial

> **NCT02036008** · NA · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 150 (estimated)

## Conditions studied

- Cancer
- Metastases
- Liver Neoplasms

## Interventions

- **OTHER:** Liver MRI with Gdfos
- **OTHER:** Liver MRI with EcGd

## Key facts

- **NCT ID:** NCT02036008
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2014-12
- **Final completion:** 2015-07
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2014-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02036008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02036008, "Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02036008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*